Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
PaperCitations, authors & open-access status
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 6,558 citations, 2015 year and closed oa status.
6,558
Citations
2015
Year
closed
OA Status